Physician profile

Tracy Mix

Physician Assistant · Avon, OH

NPI 1366947533

$665.29

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$463.85

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Phathom Pharmaceuticals, INC. $130.39 2024 Voquezna
Inspire Medical Systems, INC. $126.65 2024 Inspire
Teleflex LLC $113.67 2023 Urolift
Medacta USA, INC. $107.79 2021
Neurelis, INC. $93.14 2024 Valtoco
Organogenesis INC. $39.96 2021
Depuy Synthes Sales INC. $19.13 2022
Ferring Pharmaceuticals INC. $18.67 2022
Heraeus Medical, LLC. $15.89 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Tracy Mix

$665.29

in general payments reported 2019-2025

Years
2021-2024
Top company
Phathom Pharmaceuticals, INC.

https://glasscript.com/doctor/11048259/tracy-mix

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.